TMEM63B and colitis: To assess the impact of TMEM63B on ISC proliferation, we treated mice with DSS (a colitis model) and found that TMEM63B cKO mice exhibited more severe colitis symptoms compared to controls (Figure 5A,B), including significant body weight loss and shorter colon length (Figure 5A–D).